Perindoprilarginin Krka 5 mg filmovertrukne tabletter
Versorgungsengpass · Increased demand
Active ingredient: Perindopril (Perindoprilarginin)

Official notices covering supply interruptions, limited availability and resumed supply. Each notice identifies the product, active ingredient, status and reported period.
151 notices · Page 3 / 4
← Europe overviewRecorded notices include resolved cases. The data check date differs from the modification date of an individual authority notice.
Versorgungsengpass · Increased demand
Active ingredient: Perindopril (Perindoprilarginin)
Versorgungsengpass · Production problems
Active ingredient: Fluorescein, oxybuprocain (fluoresceinnatrium, oxybuprocainhydrochlorid)
Versorgungsengpass · Supply difficulties
Active ingredient: Latanoprost, timolol
Versorgungsengpass · Supply difficulties
Active ingredient: Latanoprost, timolol
Versorgungsengpass · Production problems
Active ingredient: Latanoprost, timolol
Versorgungsengpass · Supply difficulties
Active ingredient: Siltuximab
Versorgungsengpass · Increased demand
Active ingredient: Loratadin
Versorgungsengpass · Commercial reasons
Active ingredient: Loratadin
Versorgungsengpass · Production problems
Active ingredient: Ketoconazol
Versorgungsengpass · Production problems
Active ingredient: Codein, paracetamol (codeinphosphathemihydrat, paracetamol)
Versorgungsengpass · Production problems
Active ingredient: Carbamazepin
Versorgungsengpass · Quality problems
Active ingredient: Fluorescein (Fluoresceinnatrium)
Versorgungsengpass · Supply difficulties
Active ingredient: Avanafil
Versorgungsengpass · Supply difficulties
Active ingredient: Avanafil
Versorgungsengpass · Supply difficulties
Active ingredient: Avanafil
Versorgungsengpass · Supply difficulties
Active ingredient: Paracetamol
Versorgungsengpass · Supply difficulties
Active ingredient: Paracetamol
Versorgungsengpass · Commercial reasons
Active ingredient: Insulin aspart; insulin degludec
Versorgungsengpass · Commercial reasons
Active ingredient: nicht angegeben
Versorgungsengpass · Increased demand
Active ingredient: nicht angegeben
Versorgungsengpass · Production problems
Active ingredient: nicht angegeben
Versorgungsengpass · Commercial reasons
Active ingredient: nicht angegeben
Versorgungsengpass · Increased demand
Active ingredient: Everolimus
Versorgungsengpass · Supply difficulties
Active ingredient: Fluorescein (Fluoresceinnatrium)
Versorgungsengpass · Commercial reasons
Active ingredient: Insulin detemir
Versorgungsengpass · Commercial reasons
Active ingredient: Insulin detemir
Versorgungsengpass · Production problems
Active ingredient: Mannitol
Versorgungsengpass · Increased demand
Active ingredient: Salbutamol (salbutamolsulfat)
Versorgungsengpass · Quality problems
Active ingredient: Miconazol
Versorgungsengpass · Increased demand
Active ingredient: Tolterodin (tolterodintartrat)
Versorgungsengpass · Production problems
Active ingredient: Hypromellose
Versorgungsengpass · Supply difficulties
Active ingredient: Midazolam (Midazolamhydrochlorid)
Versorgungsengpass · Production problems
Active ingredient: Ropinirol (Ropinirolhydrochlorid)
Versorgungsengpass · Increased demand
Active ingredient: Skovflåtbåren meningoencephalitisvirus (TBE-virus)
Versorgungsengpass · Supply difficulties
Active ingredient: Pregabalin
Versorgungsengpass · Production problems
Active ingredient: Rivastigmin (Rivastigminhydrogentartrat)
Versorgungsengpass · Production problems
Active ingredient: Tolterodin (Tolterodintartrat)
Versorgungsengpass · Supply difficulties
Active ingredient: Tolterodin (Tolterodintartrat)
Versorgungsengpass · Production problems
Active ingredient: Quetiapin fumarat
Versorgungsengpass · Production problems
Active ingredient: Quetiapin fumarat
Versorgungsengpass · Production problems
Active ingredient: Ropinirol (Ropinirolhydrochlorid)
Versorgungsengpass · Production problems
Active ingredient: Nafarelin (Nafarelinacetat)
Versorgungsengpass · Production problems
Active ingredient: Fingolimod (Fingolimodhydrochlorid)
Versorgungsengpass · Commercial reasons; permanent market withdrawal
Active ingredient: Clioquinol; Flumethason (Flumethasonpivalat)
Versorgungsengpass · Supply difficulties
Active ingredient: Pneumococcal polysaccharide serotypes 1, 2, 3, 4, 5, 6B, 7F, 8, 9N, 9V, 10A, 11A, 12F, 14, 15B, 17F, 18C, 19A, 19F, 20, 22F, 23F and 33F
Versorgungsengpass · Production problems
Active ingredient: Alirocumab
Ended · Supply difficulties
Active ingredient: nicht angegeben
Ended · Supply difficulties
Active ingredient: nicht angegeben
Ended · Supply difficulties
Active ingredient: nicht angegeben
Ended · Increased demand
Active ingredient: nicht angegeben